Clinical Trial Update: Phase II Dose Ranging Study of Artesunate [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase II dose-ranging study of artesunate for falciparum malaria, including uncomplicated malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria Falciparum
• Malaria Uncomplicated

Drugs mentioned

• Artesunate (artesunate)

Snippet

Sponsor: U.S. Army Office of the Surgeon General | Conditions: Falciparum Malaria, Uncomplicated Malaria | Phase 2 | Status: COMPLETED